VBI Vaccines Inc/BC financial data

Symbol
VBIVQ on OTC
Industry
Pharmaceutical Preparations
Location
160 Second Street, Cambridge, Cambridge, MA
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Former names
SciVac Therapeutics Inc. (to 6/13/2016), LEVON RESOURCES LTD. (to 7/17/2015), LEVON RESOURCES LTD (to 9/7/2010)
Latest financial report
10-Q - Q1 2024 - May 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 56 % -75.1%
Quick Ratio 12.7 % -22.3%
Return On Equity -1.08K % -574%
Return On Assets -94.4 % -23.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.4M shares -89%
Common Stock, Shares, Outstanding 25.2M shares +193%
Entity Public Float 22M USD -85.8%
Common Stock, Value, Issued 455M USD +2.88%
Weighted Average Number of Shares Outstanding, Basic 24.6M shares +186%
Weighted Average Number of Shares Outstanding, Diluted 24.6M shares +186%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.41M USD +553%
Research and Development Expense 8.76M USD -46.2%
General and Administrative Expense 52.8M USD +60.2%
Operating Income (Loss) -72.2M USD +15.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -83M USD +30.7%
Net Income (Loss) Attributable to Parent -83M USD +30.7%
Earnings Per Share, Basic -3.54 USD/shares -197%
Earnings Per Share, Diluted -3.54 USD/shares +77.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 101M USD -6.37%
Accounts Receivable, after Allowance for Credit Loss, Current 227K USD -19.2%
Inventory, Net 9.94M USD +46.9%
Other Assets, Current 1.99M USD +0.91%
Assets, Current 26.4M USD -49.1%
Property, Plant and Equipment, Net 9.09M USD -22.3%
Operating Lease, Right-of-Use Asset 1.95M USD -34.9%
Intangible Assets, Net (Excluding Goodwill) 35.7M USD -38.9%
Goodwill 1.11M USD -48.1%
Other Assets, Noncurrent 1.21M USD -8.01%
Assets 75.4M USD -41.3%
Accounts Payable, Current 8.87M USD -9.82%
Employee-related Liabilities, Current 1.97M USD -22.1%
Contract with Customer, Liability, Current 9.62M USD +1382%
Liabilities, Current 77.6M USD +162%
Contract with Customer, Liability, Noncurrent 1.61M USD -18%
Operating Lease, Liability, Noncurrent 1.14M USD -43.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 31.8M USD +13.5%
Retained Earnings (Accumulated Deficit) -600M USD -16%
Stockholders' Equity Attributable to Parent -5.47M USD -112%
Liabilities and Equity 75.4M USD -41.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -11.8M USD +45.7%
Net Cash Provided by (Used in) Financing Activities 843K USD
Net Cash Provided by (Used in) Investing Activities -151K USD +71.7%
Common Stock, Shares, Issued 25.2M shares +193%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.1M USD +50.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.57M USD +8.91%
Deferred Tax Assets, Valuation Allowance 117M USD +18.4%
Deferred Tax Assets, Gross 117M USD +18.4%
Operating Lease, Liability 1.97M USD -34.7%
Payments to Acquire Property, Plant, and Equipment 151K USD -71.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -79.2M USD +16.9%
Lessee, Operating Lease, Liability, to be Paid 2.24M USD -37.8%
Property, Plant and Equipment, Gross 20.1M USD -0.9%
Operating Lease, Liability, Current 831K USD -15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 584K USD -14.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 663K USD -44.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -7.69%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 276K USD -53.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 160K USD -73.1%
Deferred Tax Assets, Operating Loss Carryforwards 109M USD +10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 163K USD -73.7%
Operating Lease, Payments 341K USD +26.8%
Additional Paid in Capital 87.7M USD +10.9%
Depreciation, Depletion and Amortization 493K USD -2.95%
Interest Expense 6.79M USD +51%